Study of NTLA-2001 for Patients with Transthyretin Amyloidosis and Heart Disease
- Substances:DexamethasoneFamotidine+4
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Dexamethasone
- Sponsor:Intellia Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to the Netherlands625 clinical trials in Utrecht, The Netherlands across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
The NetherlandsStudy of Narsoplimab for Children with High-Risk Blood Vessel Damage After Stem Cell Transplant
The NetherlandsStudy of cefuroxime and metronidazole to prevent infections after Whipple's procedure in patients with high risk of bile contamination
The NetherlandsStudy of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels
The NetherlandsStudy of RMC-6291 and Pembrolizumab with or without Chemotherapy for Patients with Advanced KRAS G12C Mutated Lung Cancer
The NetherlandsStudy on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma
The NetherlandsStudy of RMC-6236 and Pembrolizumab with or without Chemotherapy for Patients with RAS-Mutated Non-Small Cell Lung Cancer
The NetherlandsStudy on Rosuvastatin and Placebo for Patients with Statin Intolerance and High Cardiovascular Risk
The NetherlandsStudy on Personalized Dosing of Emicizumab for Patients with Congenital Hemophilia A
The NetherlandsStudy on the Effectiveness of Floxuridine and Drug Combination for Patients with Unresectable Colorectal Liver Metastases
The NetherlandsStudy on Sentinel Lymph Node Biopsy for Parotid Gland Cancer Using Gallium (68Ga) Chloride and Tilmanocept in Patients Undergoing Parotidectomy and Neck Dissection
The NetherlandsStudy on Long-Term Safety of mRNA-3705 for Patients with Methylmalonic Acidemia (MMA)
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on TTR amyloidosis and heart disease treatments, investigating new therapeutic approaches for cardiac conditions. Clinical trials evaluate novel medications for improving patient mobility and cardiac function.
Research aims to enhance quality of life for patients with hereditary and wild-type ATTR cardiomyopathy.
Comprehensive studies in gastric cancer, bladder cancer, and neuroblastoma, exploring innovative treatment combinations and diagnostic methods.
Advanced trials combining established treatments with novel approaches to improve patient outcomes.
Groundbreaking research in Amyotrophic Lateral Sclerosis and chronic inflammatory conditions, focusing on innovative treatments and disease modification strategies.
Studies aim to develop effective treatments for rare and challenging neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.